A detailed history of Gamma Investing LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 32 shares of VNDA stock, worth $155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 198 83.84%
Holding current value
$155
Previous $929,000 83.53%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

SELL
$4.41 - $5.46 $732 - $906
-166 Reduced 83.84%
32 $153,000
Q3 2024

Oct 04, 2024

SELL
$4.61 - $6.34 $175 - $240
-38 Reduced 16.1%
198 $929,000
Q2 2024

Jul 02, 2024

BUY
$3.91 - $6.5 $922 - $1,534
236 New
236 $1.33 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $274M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.